0001104659-21-151330.txt : 20211217 0001104659-21-151330.hdr.sgml : 20211217 20211217202602 ACCESSION NUMBER: 0001104659-21-151330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211215 FILED AS OF DATE: 20211217 DATE AS OF CHANGE: 20211217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilboa David Abraham CENTRAL INDEX KEY: 0001883353 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40825 FILM NUMBER: 211503380 MAIL ADDRESS: STREET 1: C/O WARBY PARKER INC. STREET 2: 233 SPRING STREET, 6TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10013 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Warby Parker Inc. CENTRAL INDEX KEY: 0001504776 STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851] IRS NUMBER: 800423634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 BUSINESS PHONE: (646) 847-7215 MAIL ADDRESS: STREET 1: 233 SPRING STREET STREET 2: 6TH FLOOR EAST CITY: NEW YORK STATE: NY ZIP: 10013 FORMER COMPANY: FORMER CONFORMED NAME: JAND, Inc. DATE OF NAME CHANGE: 20101102 4 1 tm2135330-8_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-15 0 0001504776 Warby Parker Inc. WRBY 0001883353 Gilboa David Abraham C/O WARBY PARKER INC., 233 SPRING STREET, 6TH FLOOR EAST NEW YORK NY 10013 1 1 0 0 Co-Chief Executive Officer Class A Common Stock 2021-12-15 4 C 0 250000 0 A 250000 D Class A Common Stock 2021-12-15 4 S 0 225564 43.3247 D 24436 D Class A Common Stock 2021-12-15 4 S 0 24436 43.9553 D 0 D Class A Common Stock 2021-12-16 4 C 0 1732 0 A 1732 D Class A Common Stock 2021-12-16 4 S 0 1732 44.59 D 0 D Class A Common Stock 2021-12-17 4 C 0 115000 0 A 115000 D Class A Common Stock 2021-12-17 4 S 0 115000 44.923 D 0 D Stock Option (Right to Buy) 0.72 2021-12-15 4 M 0 427000 0 D Class B Common Stock 427000 228490 D Class B Common Stock 2021-12-15 4 M 0 427000 0 A Class A Common Stock 427000 6703796 D Class B Common Stock 2021-12-15 4 C 0 250000 0 D Class A Common Stock 250000 6453796 D Restricted Stock Units 2021-12-16 4 M 0 1732 0 D Class B Common Stock 1732 939020 D Class B Common Stock 2021-12-16 4 M 0 1732 0 A Class A Common Stock 1732 6455528 D Class B Common Stock 2021-12-16 4 C 0 1732 0 D Class A Common Stock 1732 6453796 D Stock Option (Right to Buy) 0.72 2021-12-17 4 M 0 228490 0 D Class B Common Stock 228490 0 D Class B Common Stock 2021-12-17 4 M 0 228490 0 A Class A Common Stock 228490 6682286 D Class B Common Stock 2021-12-17 4 C 0 115000 0 D Class A Common Stock 115000 6567286 D Class B Common Stock Class A Common Stock 0 2131770 I By David A. Gilboa 2012 Family Trust The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $42.76 to $43.72. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $43.775 to $44.1017. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Sale of shares to cover taxes due on restricted stock units that vested on October 1, 2021 and November 1, 2021. The price reported in Column 4 is a weighted average price. These shares were sold to cover taxes due on option exercises reported in Table II of this Form 4 in multiple transactions at prices ranging from $44.72 to $45.13. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Stock option was granted on July 27, 2012, is fully vested, and will expire on July 26, 2022. The Class B Common Stock is convertible at any time at the option of the holder into the Issuer's Class A Common Stock on a one-to-one basis. The Class B Common Stock will automatically convert intoshares of the Issuer's Class A Common Stock on a one-to-one basis upon the earlier of (i) transfer of Class B common stock to a person or entity that is not in the transferor's permitted ownership group, (ii) October 1, 2031, (iii) with respect to any Class B common stock held by any person or entity in Neil Blumenthal's permitted ownership group, (A) such time as Neil Blumenthal is removed or resigns from theboard of directors, or otherwise ceases to serve as a director, (B) such time as Neil Blumenthal ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Neil Blumenthal, and (iv) with respect to any Class B common stock held by any person or entity in Dave Gilboa's permitted ownership group, (A) such time as Dave Gilboa is removed or resigns from the board of directors, orotherwise ceases to serve as a director, (B) such time as Dave Gilboa ceases to be either an employee, officer or consultant of the Company or any of its subsidiaries, or (C) the date that is 12 months after the death or disability of Dave Gilboa. Each Restricted Stock Unit represents a contingent right to receive one share of the Company's Class A Common Stock. This filing relates to the occurrence of a RSU vesting event. The restricted stock units will vest in 60 monthly installments beginning on July 1, 2021, will expire on June 15, 2031. /s/ Hyung Bak, Attorney-in-Fact 2021-12-17